Director
Biopharma Services, Canada
With 11 years of experience in advancing clinical research, I possess a deep understanding of the drug development process. My career has spanned both operational and scientific domains, with a successful track record at prominent organizations such as Covance – LabCorp and Merck.
In my current role as Director of Pharmacokinetics at Biopharma Services Inc., I leverage my expertise to guide the successful execution of clinical trials. My in-depth knowledge of pharmacokinetic principles, including absorption, distribution, metabolism, and excretion, enables me to contribute significantly to study design, data analysis, and regulatory submissions.
I am passionate about advancing medical science and committed to delivering high-quality data that informs critical decision-making in drug development. At ASCPT 2025, I am pleased to introduce our poster entitled "EVALUATING DRUG-DRUG INTERACTIONS WITH ACID-REDUCDING AGENTS: INSIGHTS FROM FDA GUIDANCE AND RECENT APPROVALS". This poster overviews the FDA approval packages for gastric pH-dependence drugs and reviews various approaches to evaluating their interaction with ARAs withitn this decay.